Stay Informed on Corporate Sustainability

Author: Archie Villaflores

At SGS ISL Cork, the commitment to scientific excellence extends beyond the laboratory. To meet the growing demand for skilled professionals, SGS has strengthened its partnership with University College Cork (UCC) to develop future industry leaders through research and mentoring.

Author: Jed Nykolle Harme

Ireland’s biopharmaceutical and chemical industries are among the country’s greatest success stories, driving exports, innovation, and high-value employment. Yet sustaining that success depends on one critical factor: a skilled and adaptable workforce.

Author: Jed Nykolle Harme

The pharma and life sciences industry stands at a pivotal moment, defined by rapid innovation, evolving regulations, and the constant pursuit of excellence. Yet, amid the complexity of scientific advancement, one principle remains clear: progress depends on people. Building a skilled, forward-thinking workforce has become central to sustaining Ireland’s position as a global leader in BioPharmaChem and beyond. Empowering Ireland’s BioPharmaChem Workforce through funded, industry-led training showcases how coordinated investment in education and industry partnerships is reshaping talent pipelines. The initiative reflects a broader commitment to preparing professionals for the next generation of biopharma manufacturing. SGS ISL Cork’s academic collaboration reinforces this vision by nurturing the next wave of scientific leaders through applied research and mentoring. It demonstrates how academia and industry can jointly accelerate innovation. Meanwhile, Alice Redmond’s appointment to the Pharma Industry Awards 2025 Judging Coordinator adds further expertise to a platform that celebrates achievement and drives excellence across the sector. These developments highlight an industry investing deeply in its people, ensuring that Ireland’s leadership in pharma and life sciences continues to grow stronger and more resilient.

Author: Jed Nykolle Harme

With over 30 years of experience in the pharmaceutical, medical device, and biotechnology sectors, Alice Redmond brings unparalleled expertise and leadership to the judging panel of the Pharma Industry Awards 2025.

Author: Yahoo News

Anthropic launches Claude for Life Sciences, its first major life science venture, enabling AI-driven research, data analysis, and regulatory drafting to accelerate drug discovery through partnerships with Benchling, PubMed, and 10x Genomics.

Author: REUTERS

Merck KGaA shares fell 7% after the company issued 2026 guidance projecting low-to-mid single-digit organic sales growth and stable EBITDA, while healthcare sales temporarily moderate. CEO Belen Garijo highlighted life science M&A priorities.

Author: Business Wire

Merck to acquire JSR Life Sciences’ chromatography business, integrating Amsphere Protein A technologies to enhance monoclonal antibody production, expand bioprocessing capabilities, and improve global biologics manufacturing efficiency.

Author: RTE

Chemist Warehouse opens its 16th Irish store at Wexford Retail Park, creating 22 jobs, as part of plans to expand further in Ireland, offering affordable healthcare products and services.

Author: Jed Nykolle Harme

Across the Pharma and Life Sciences landscape, a new rhythm of innovation and resilience is taking shape. The sector’s evolution is not defined solely by scientific milestones but by the steady alignment of leadership, investment, and advanced capability, the cornerstones of sustained progress. In Matt Moran brings three decades of biopharma leadership to the judging panel, experience meets foresight as one of Ireland’s most respected industry figures helps chart the future of excellence and collaboration. This emphasis on leadership complements the sector-wide momentum captured in UK life sciences gains momentum with Moderna investment, where strategic funding signals renewed confidence in research-driven growth. Meanwhile, SGS ISL expands capabilities with polarised light microscopy for asbestos testing reflects how precision science continues to strengthen quality assurance and public health outcomes. These developments illustrate a sector not merely adapting but advancing — guided by vision, underpinned by rigour, and committed to continuous improvement.

Author: Jed Nykolle Harme

Matt Moran, CEO of Matt Moran Consulting, joins the judging panel of the Pharma Industry Awards 2025 as Judging Coordinator, bringing more than 30 years of leadership in the biopharmaceutical sector.